Topiramate Tablet, Film Coated
Product Images NDC 68788-8817
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68788-8817). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (9df497de Be9f 4244 A769 A72a0e64dc42 01)
Image (9df497de Be9f 4244 A769 A72a0e64dc42 02)
This text provides data on cumulative rates for time to the first seizure based on the comparison between two groups taking different dosages of topiramate - 50 mg/day and 400 mg/day. The sample sizes for each group are 234 and 236, respectively. The p-value for the comparison is very low - p=0.00002. The graph shows the time in days on the x-axis and the cumulative rates on the y-axis, with the curves representing the two different dosages.*
Image (9df497de Be9f 4244 A769 A72a0e64dc42 03)
Topiramate Tablets 25mg (9df497de Be9f 4244 A769 A72a0e64dc42 04)
This is a description of Topiramate Tablets 25mg, a generic for Topamax. The film-coated tablets contain 25mg of topiramate, USP. The pharmaceutical details specify the manufacturer as Unichem Laboratories Ltd. The tablets are round, yellow, and imprinted with U/115. Storage instructions recommend storing at 20°C to 25°C (68°F to 77°F) and protecting from moisture. The text emphasizes caution against transferring the drug to anyone other than the prescribed patient due to federal law restrictions.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.